Showing results (2611-2620 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|June 10, 2019
Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cellsEstefany Ingrid Medina-Reyes, Marco Antonio Mancera-Rodríguez, Norma Laura Delgado-Buenrostro, et al.
Investigational New Drugs|June 10, 2019
Activation of IGF-1R pathway and NPM-ALK G1269A mutation confer resistance to crizotinib treatment in NPM-ALK positive lymphomaYanrong Li, Kai Wang, Na Song, et al.
Investigational New Drugs|June 10, 2019
CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cellsJelena Dinić, Carla Ríos-Luci, Ieva Karpaviciene, et al.
Investigational New Drugs|June 10, 2019
The influence of the coadministration of the p-glycoprotein modulator elacridar on the pharmacokinetics of lapatinib and its distribution in the brain and cerebrospinal fluidAgnieszka Karbownik, Katarzyna Sobańska, Włodzimierz Płotek, et al.
Investigational New Drugs|June 8, 2019
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in JapanSadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa, et al.
Investigational New Drugs|October 11, 2018
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancerG Weldon Gilcrease, David D Stenehjem, Mark L Wade, et al.
Investigational New Drugs|October 13, 2018
A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-βClinton Yam, Rashmi K Murthy, Gaiane M Rauch, et al.
Investigational New Drugs|May 12, 2019
Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomideJavier Megías, Alba Martínez, Teresa San-Miguel, et al.
Investigational New Drugs|January 1, 1986
Role of metabolism in effects of diflubenzuron on growth of B16 melanomas in miceV K Jenkins, R R Perry, A E Ahmed, et al.
Investigational New Drugs|September 29, 2021
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practiceYuka Hayakawa, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Pageof 372